NP / PA
Canterbury Pediatrics, PC
Canterbury Pediatrics, PC was paid $1.55M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoCANTERBURY PEDIATRICS, PC
MONROE, CT 06468
MONROE, CT 06468
33aNPI1528077286assigned 08/05/2006
33bProvider typePediatric Nurse Practitioner
28Total paid$1.55M
24GClaims33,322
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Connecticut
Rank by total paid#7 of 31
Median peer was paid$8K
This provider vs. median205×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,916 | $235K | |
| 2019 | 5,202 | $222K | |
| 2020 | 3,650 | $149K | |
| 2021 | 4,608 | $202K | |
| 2022 | 5,557 | $289K | |
| 2023 | 4,887 | $230K | |
| 2024incomplete | 4,502 | $226K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 8,985 | 7,767 | $633K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 5,739 | 4,949 | $611K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.0% | 2,430 | 2,233 | $77K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 1,259 | 1,164 | $54K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.9% | 1,697 | 1,474 | $45K |
| 96127 | 1.6% | 1,364 | 1,257 | $26K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,201 | 1,041 | $22K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 909 | 844 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,295 | 1,147 | $13K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 90 | 89 | $11K |
| 99173 | <1% | 1,916 | 1,808 | $11K | |
| 92551 | <1% | 1,798 | 1,697 | $10K |
19 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 88 | $10K |
| 87634 | <1% | 110 | $6K | |
| 96160 | <1% | 115 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 46 | $1K |
| 0071A | <1% | 31 | $840.00 | |
| 0072A | <1% | 13 | $520.00 | |
| 99051 | <1% | 62 | $503.44 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 56 | $428.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 13 | $261.17 |
| 36416 | <1% | 13 | $40.56 | |
| 81002 | 0% | 659 | $0.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 56 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 30 | $0.00 |
| 90686 | 0% | 1,494 | $0.00 | |
| 88738 | 0% | 1,560 | $0.00 | |
| 91307 | 0% | 73 | $0.00 | |
| 90656 | 0% | 152 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 43 | $0.00 |
| 85018 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTSALAPATANIS, JOHN (MD)